3401 related articles for article (PubMed ID: 680624)
21. Tumor antigens isolated from a patient with vitiligo and T-cell-infiltrated melanoma.
Kiniwa Y; Fujita T; Akada M; Ito K; Shofuda T; Suzuki Y; Yamamoto A; Saida T; Kawakami Y
Cancer Res; 2001 Nov; 61(21):7900-7. PubMed ID: 11691810
[TBL] [Abstract][Full Text] [Related]
22. Human leucocyte migration under agarose: migration inhibition by soluble and tumor antigens with special reference to antimelanoma activity in healthy blacks.
Tautz C; Khuen F; Ax W
Z Immunitatsforsch Exp Klin Immunol; 1974 Jun; 147(2):155-61. PubMed ID: 4283006
[No Abstract] [Full Text] [Related]
23. The expression of tumor-associated antigens in primary and metastatic human malignant melanoma.
Brüggen J; Bröcker EB; Suter L; Redmann K; Sorg C
Behring Inst Mitt; 1984 May; (74):19-23. PubMed ID: 6477352
[TBL] [Abstract][Full Text] [Related]
24. Postoperative depression of tumour-directed cell-mediated immunity in patients with malignant disease.
Cochran AJ; Spilg WG; Mackie RM; Thomas CE
Br Med J; 1972 Oct; 4(5832):67-70. PubMed ID: 5077468
[TBL] [Abstract][Full Text] [Related]
25. Detection of a breast tissue-associated antigen by antiserum to Raji cell-bound circulating immune complexes of human breast cancer.
Koestler TP; Papsidero LD; Nemoto T; Chu TM
Cancer Res; 1981 Jul; 41(7):2900-7. PubMed ID: 7018673
[TBL] [Abstract][Full Text] [Related]
26. Immunophenotype of human melanoma cells in different metastases.
Bystryn JC; Bernstein P; Liu P; Valentine F
Cancer Res; 1985 Nov; 45(11 Pt 2):5603-7. PubMed ID: 2413993
[TBL] [Abstract][Full Text] [Related]
27. Characterization of human anti-high molecular weight-melanoma-associated antigen single-chain Fv fragments isolated from a phage display antibody library.
Desai SA; Wang X; Noronha EJ; Kageshita T; Ferrone S
Cancer Res; 1998 Jun; 58(11):2417-25. PubMed ID: 9622083
[TBL] [Abstract][Full Text] [Related]
28. Human melanoma tumor-specific antigens (II): Comparison of antigens from tumor cell plasma membranes of five melanoma patients.
Khosravi M; Preddie E; Hartmann D; Lewis MG
Cancer Biochem Biophys; 1980; 4(3):195-202. PubMed ID: 7438029
[TBL] [Abstract][Full Text] [Related]
29. The cell-mediated immunity in patients with malignant melanoma.
Fixa B; Komárková O; Kraus Z; Simková H
Neoplasma; 1978; 25(3):353-7. PubMed ID: 683378
[TBL] [Abstract][Full Text] [Related]
30. Isolation of a soluble tumor-associated antigen from human melanoma.
Roth JA; Holmes EC; Reisfeld RA; Slocum HK; Morton DL
Cancer; 1976 Jan; 37(1):104-10. PubMed ID: 1247946
[TBL] [Abstract][Full Text] [Related]
31. Human monoclonal antibodies directed against melanoma tumor-associated antigens.
Kan-Mitchell J; Imam A; Kempf RA; Taylor CR; Mitchell MS
Cancer Res; 1986 May; 46(5):2490-6. PubMed ID: 3697990
[TBL] [Abstract][Full Text] [Related]
32. Properties of tumor-specific antigen solubilized by hypertonic potassium chloride.
Leonard EJ; Meltzer MS; Borsos T; Rapp HJ
Natl Cancer Inst Monogr; 1972 Dec; 35():129-34. PubMed ID: 4572822
[No Abstract] [Full Text] [Related]
33. Tumor-associated antigens in spent medium of human melanoma cells: immunochemical characterization with xenoantisera.
Galloway DR; McCabe RP; Pellegrino MA; Ferrone S; Reisfeld RA
J Immunol; 1981 Jan; 126(1):62-6. PubMed ID: 7451981
[TBL] [Abstract][Full Text] [Related]
34. Antigenic profile of tumor progression stages in human melanocytic nevi and melanomas.
Elder DE; Rodeck U; Thurin J; Cardillo F; Clark WH; Stewart R; Herlyn M
Cancer Res; 1989 Sep; 49(18):5091-6. PubMed ID: 2548711
[TBL] [Abstract][Full Text] [Related]
35. A rapid assay for stimulation of human lymphocytes by tumor-associated antigens.
Roth JA; Grimm EA; Morton DL
Cancer Res; 1976 Sep; 36(9 pt.1):3001-10. PubMed ID: 975069
[TBL] [Abstract][Full Text] [Related]
36. Suppression of melanoma development and regression of melanoma in xiphophorine fish after treatment with immune RNA.
Wurm F; Pauli G; Vielkind J
Cancer Res; 1981 Sep; 41(9 Pt 1):3377-83. PubMed ID: 6167347
[TBL] [Abstract][Full Text] [Related]
37. Identification of immunogenic human melanoma antigens in a polyvalent melanoma vaccine.
Bystryn JC; Henn M; Li J; Shroba S
Cancer Res; 1992 Nov; 52(21):5948-53. PubMed ID: 1382848
[TBL] [Abstract][Full Text] [Related]
38. Isolation of a soluble tumor-associated antigen from human renal cell carcinoma by gradient acrylamide gel electrophoresis.
Wright GL; Schellhammer PF; Faulconer RL
Cancer Res; 1977 Nov; 37(11):4228-32. PubMed ID: 911404
[No Abstract] [Full Text] [Related]
39. Induction of IgG antibodies directed to a M(r) 31,000 melanoma antigen in patients immunized with vaccinia virus melanoma oncolysates.
Berthier-Vergnes O; Portoukalian J; Lefthériotis E; Doré JF
Cancer Res; 1994 May; 54(9):2433-9. PubMed ID: 8162593
[TBL] [Abstract][Full Text] [Related]
40. Immunochemical characterization of fetal antigen isolated from spent medium of a human melanoma cell line.
Gupta RK; Morton DL
J Natl Cancer Inst; 1983 Jun; 70(6):993-1004. PubMed ID: 6190035
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]